224 related articles for article (PubMed ID: 18199719)
41. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma.
Hirvonen A; Pelin K; Tammilehto L; Karjalainen A; Mattson K; Linnainmaa K
Cancer Res; 1995 Jul; 55(14):2981-3. PubMed ID: 7606714
[TBL] [Abstract][Full Text] [Related]
42. GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population.
Chatzimichalis M; Xenellis J; Tzagaroulakis A; Sarof P; Banis K; Gazouli M; Bibas A
J Laryngol Otol; 2010 Mar; 124(3):318-23. PubMed ID: 19922706
[TBL] [Abstract][Full Text] [Related]
43. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.
Demokan S; Suoglu Y; Gözeler M; Demir D; Dalay N
Mol Biol Rep; 2010 Oct; 37(7):3217-26. PubMed ID: 19898993
[TBL] [Abstract][Full Text] [Related]
44. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
[TBL] [Abstract][Full Text] [Related]
45. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
[TBL] [Abstract][Full Text] [Related]
46. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan.
Chiou HL; Wu MF; Chien WP; Cheng YW; Wong RH; Chen CY; Lin TS; Lee H
Cancer Lett; 2005 Jun; 223(1):93-101. PubMed ID: 15890241
[TBL] [Abstract][Full Text] [Related]
47. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
[TBL] [Abstract][Full Text] [Related]
48. Lung cancer and mutations at the polymorphic NAT2 gene locus.
Martínez C; Agúndez JA; Olivera M; Martín R; Ladero JM; Benítez J
Pharmacogenetics; 1995 Aug; 5(4):207-14. PubMed ID: 8528267
[TBL] [Abstract][Full Text] [Related]
49. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441
[TBL] [Abstract][Full Text] [Related]
50. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA
Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189
[TBL] [Abstract][Full Text] [Related]
51. Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.
Costa S; Pinto D; Morais A; Vasconcelos A; Oliveira J; Lopes C; Medeiros R
Prostate; 2005 Aug; 64(3):246-52. PubMed ID: 15717312
[TBL] [Abstract][Full Text] [Related]
52. N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus.
Cooper GS; Treadwell EL; Dooley MA; St Clair EW; Gilkeson GS; Taylor JA
J Rheumatol; 2004 Jan; 31(1):76-80. PubMed ID: 14705222
[TBL] [Abstract][Full Text] [Related]
53. N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.
Ricart E; Taylor WR; Loftus EV; O'Kane D; Weinshilboum RM; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
Am J Gastroenterol; 2002 Jul; 97(7):1763-8. PubMed ID: 12135032
[TBL] [Abstract][Full Text] [Related]
54. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue.
Bell DA; Badawi AF; Lang NP; Ilett KF; Kadlubar FF; Hirvonen A
Cancer Res; 1995 Nov; 55(22):5226-9. PubMed ID: 7585580
[TBL] [Abstract][Full Text] [Related]
55. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
56. Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants.
Briggs FB; Acuna B; Shen L; Ramsay P; Quach H; Bernstein A; Bellesis KH; Kockum IS; Hedström AK; Alfredsson L; Olsson T; Schaefer C; Barcellos LF
Epidemiology; 2014 Jul; 25(4):605-14. PubMed ID: 24625537
[TBL] [Abstract][Full Text] [Related]
57. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
[TBL] [Abstract][Full Text] [Related]
59. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
[TBL] [Abstract][Full Text] [Related]
60. Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer.
Yeh CC; Sung FC; Tang R; Chang-Chieh CR; Hsieh LL
Dis Colon Rectum; 2009 Jan; 52(1):104-11. PubMed ID: 19273964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
